Skip to main content

Illinois IGB


CRISPR-Cas13 targets proteins causing ALS, Huntington's disease in mouse nervous system

January 19, 2022

A single genetic mutation can have profound consequences, as demonstrated in neurodegenerative diseases such as amyotrophic lateral sclerosis or Huntington’s disease. A new study by University of Illinois Urbana-Champaign researchers used a targeted CRISPR technique in the central nervous systems of mice to turn off production of mutant proteins that can cause ALS and Huntington’s disease.

January 19, 2022

Related Articles

Subscribe to Huntington's